首页> 美国卫生研究院文献>Scientific Reports >A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy
【2h】

A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy

机译:同时进行二合一siRNA递送的RNA纳米技术平台及其在协同RNAi治疗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Incorporating multiple copies of two RNAi molecules into a single nanostructure in a precisely controlled manner can provide an efficient delivery tool to regulate multiple gene pathways in the relation of mutual dependence. Here, we show a RNA nanotechnology platform for a two-in-one RNAi delivery system to contain polymeric two RNAi molecules within the same RNA nanoparticles, without the aid of polyelectrolyte condensation reagents. As our RNA nanoparticles lead to the simultaneous silencing of two targeted mRNAs, of which biological functions are highly interdependent, combination therapy for multi-drug resistance cancer cells, which was studied as a specific application of our two-in-one RNAi delivery system, demonstrates the efficient synergistic effects for cancer therapy. Therefore, this RNA nanoparticles approach has an efficient tool for a simultaneous co-delivery of RNAi molecules in the RNAi-based biomedical applications, and our current studies present an efficient strategy to overcome multi-drug resistance caused by malfunction of genes in chemotherapy.
机译:以精确控制的方式将两个RNAi分子的多个副本整合到单个纳米结构中,可以提供一种有效的递送工具,以调节相互依赖关系中的多个基因途径。在这里,我们展示了一种用于二合一RNAi递送系统的RNA纳米技术平台,该平台可在同一RNA纳米颗粒内包含聚合的两个RNAi分子,而无需借助聚电解质缩合试剂。由于我们的RNA纳米颗粒可同时沉默两个生物学功能高度相关的靶向mRNA,因此针对多药耐药性癌细胞的联合治疗已被研究为我们的二合一RNAi递送系统的一种特殊应用,证明了癌症治疗的有效协同作用。因此,这种RNA纳米颗粒方法具有在基于RNAi的生物医学应用中同时共递送RNAi分子的有效工具,而我们目前的研究提出了一种有效的策略,可以克服由基因故障引起的多药耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号